Concepedia

Jingyi Xiang

JX

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

1999

Affiliations

Eureka Therapeutics (United States)(Current)

Cornell University

Memorial Sloan Kettering Cancer Center

Stony Brook University

State University of New York

Jingyi Xiang is an author at Eureka Therapeutics (United States) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1999–2018

10

Publications

10

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology · 2018 · 801 citations · Full text

, , +9

Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer

Hong Liu, Yiyang Xu, Jingyi Xiang et al. · Clinical Cancer Research · 2016 · 223 citations

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1

Tao Dao, Dmitry Pankov, Andrew Scott et al. · Nature Biotechnology · 2015 · 156 citations · Full text

, , +8

Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

Niloufar Ataie, Jingyi Xiang, Neal Cheng et al. · Journal of Molecular Biology · 2015 · 68 citations · Full text

, , +5

Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein

Nicholas Veomett, Tao Dao, Hong Liu et al. · Clinical Cancer Research · 2014 · 49 citations · Full text

1–5 of 10